PoD: Postoperative Neurocognitive Dysfunction: Is There Any Place for Emergency Agitation: A Prospective Cohort Trial
Study Details
Study Description
Brief Summary
Perioperative neurocognitive disorders (PND) have been studying by clinicians, particularly by anesthesiologists, pretty long, however the most inspiring advancements were achieved during the last few decades. The most recent classification of PND which includes cognitive decline diagnosed before operation (described as neurocognitive disorder); any form of acute event (postoperative delirium) and cognitive decline diagnosed up to 30 days after the procedure (delayed neurocognitive recovery) and up to 12 months (postoperative neurocognitive disorder) was proposed in 2017. However at will one can notice at least one uncertainty that pertinent to the definition of delirium, emergency delirium and not mentioned in the classification discussed agitation.
The objective of the study is to determine if there is a difference between emergence agitation and emergence delirium.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Control group Patients who have RASS < +2 and have not delirium according CAM-ICU immediately upon emergence from anesthesia |
Diagnostic Test: RASS
Richmond Agitation-Sedation Scale
Diagnostic Test: CAM-ICU
Confusion Assessment Method for the ICU
|
Agitated non-delirious group Patients who have RASS = +2 or more and have not delirium according CAM-ICU immediately upon emergence from anesthesia |
Diagnostic Test: RASS
Richmond Agitation-Sedation Scale
Diagnostic Test: CAM-ICU
Confusion Assessment Method for the ICU
|
Agitated delirium group Patients who have RASS = +2 or more and have delirium according CAM-ICU immediately upon emergence from anesthesia |
Diagnostic Test: RASS
Richmond Agitation-Sedation Scale
Diagnostic Test: CAM-ICU
Confusion Assessment Method for the ICU
|
Outcome Measures
Primary Outcome Measures
- frequency of postoperative delirium [5 postoperative day]
Percent of postoperative delirium
- frequency of postoperative cognitive dysfunction [7 postoperative day]
Percent of postoperative cognitive dysfunction
Secondary Outcome Measures
- frequency of emergence agitation [immediately upon emergence from anesthesia]
Percent of emergence agitation
- frequency of emergence delirium [immediately upon emergence from anesthesia]
Percent of emergence delirium
- Length of postoperative delirium [5 postoperative day]
Day of the end of postoperative delirium - day of onset of postoperative delirium
- Length of stay in ICU [1 year]
From ICU admission to ICU discharge
- Length of hospitalization [1 year]
From operative day to hospital discharge
- MACE [30 day]
Cardiac death or Myocardial infarction or Non-fatal cardiac arrest or Coronary revascularization
- MACE [1 year]
Cardiac death or Myocardial infarction or Non-fatal cardiac arrest or Coronary revascularization
- MACCE [30 day]
Cardiac death or Myocardial infarction or Non-fatal cardiac arrest or Coronary revascularization or Cerebrovascular accident
- MACCE [1 year]
Cardiac death or Myocardial infarction or Non-fatal cardiac arrest or Coronary revascularization or Cerebrovascular accident
- 30-day mortality [30 day]
30-day mortality
- 1-year mortality [1 year]
1-year mortality
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Age from 45 to 74 years
-
Undergoing elective orthopedic surgery
-
Provide written informed consent to participate in the PoD trial
Exclusion Criteria:
-
Undergoing emergent/urgent surgery
-
Montreal Cognitive Assessment < 18 points
-
History of mental disorders according ICD-11
-
Treated with at least one psychotropic drug
-
Patients with neuromuscular disease
-
Inability to undergo preoperative assessment for any reason
-
Previously enrolled in PoD trial
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Moscow Scientific Clinical Center | Moscow | Russian Federation | 111123 | |
2 | Main Military Clinical Hospital n.a. Acad.N. N. Burdenko | Moscow | Russian Federation |
Sponsors and Collaborators
- Negovsky Reanimatology Research Institute
Investigators
- Principal Investigator: Valery Likhvantsev, Negovsky Reanimatology Research Institute
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- PoD-2021